XML 55 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Tables)
12 Months Ended
Sep. 30, 2016
Income Tax Disclosure [Abstract]  
Schedule of Components of Income from Continuing Operations before Income Taxes
The Domestic and International components of income from continuing operations before income taxes were as follows(1):
 
2016
 
2015
 
2014
Domestic
$
(275.3
)
 
$
(107.5
)
 
$
(76.0
)
International
508.7

 
214.8

 
41.4

Total
$
233.4

 
$
107.3

 
$
(34.6
)

(1) Domestic reflects U.K. in fiscal 2016 and 2015, and U.S. federal and state in fiscal 2014.

Schedule of Significant Components of Income Taxes Related to Continuing Operations
Significant components of income taxes related to continuing operations are as follows(1):
 
2016
 
2015
 
2014
Current:
 
 
 
 
 
Domestic 
$
0.3

 
$
0.2

 
$
22.3

International 
120.5

 
67.3

 
18.9

Current income tax provision
120.8

 
67.5

 
41.2

Deferred:
 
 
 
 
 
Domestic 
$
0.7

 
$
(0.8
)
 
$
(41.9
)
International 
(377.1
)
 
(196.0
)
 
(11.9
)
Deferred income tax (benefit)
(376.4
)
 
(196.8
)
 
(53.8
)
 
$
(255.6
)
 
$
(129.3
)
 
$
(12.6
)

(1)
Schedule of Reconciliation of Income Taxes at Statutory Rate and Tax Provision
The reconciliation between Domestic income taxes at the statutory rate and the Company's provision for income taxes on continuing operations is as follows:
 
2016
 
2015
 
2014
Provision for income taxes at Domestic statutory income tax rate (1)
$
46.6

 
$
21.4

 
$
(12.1
)
   Adjustments to reconcile to income tax provision:
 
 
 
 
 
U.S. state income tax provision, net (5)

 

 
(7.0
)
Rate difference between Domestic and International jurisdictions (2)
(249.3
)
 
(152.9
)
 
(14.2
)
U.S. manufacturing deduction (5)

 

 
(2.7
)
Valuation allowances, nonrecurring
2.1

 
(2.1
)
 
0.1

Adjustments to accrued income tax liabilities and uncertain tax positions
(14.9
)
 
(7.0
)
 
(0.4
)
Interest and penalties on accrued income tax liabilities and uncertain tax positions
(16.4
)
 
0.3

 
(7.7
)
Investment in partnership

 

 
20.0

Credits, principally research and orphan drug (3) (4)
(33.7
)
 
(8.1
)
 
(0.7
)
Permanently nondeductible and nontaxable items
7.9

 
14.7

 
13.4

Other
2.1

 
4.4

 
(1.3
)
Provision for income taxes
$
(255.6
)
 
$
(129.3
)
 
$
(12.6
)
(1)
The statutory tax rate reflects the U.K. statutory tax rate of 20% for fiscal 2016 and 2015, and the U.S. federal statutory tax rate of 35% for fiscal 2014.
(2)
Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.
(3)
Due to the December 31, 2013 Research Credit tax law expiration, fiscal 2014 includes $0.7 million for the period September 28, 2013 through December 31, 2013. During fiscal 2015, the legislation was extended, with a retroactive effective date of January 1, 2014. As such, fiscal 2015 includes approximately $3.6 million of credit related to the period January 1, 2014 through September 26, 2014.
(4)
The Company realized a tax benefit of $27.4 million resulting from a U.K. tax credit on a dividend between affiliates.
(5)
For fiscal 2016, U.S. state income tax benefit of $15.1 million was combined with the rate differences between Domestic and International jurisdictions. For fiscal 2015, U.S. state income tax benefit of $34.9 million, and U.S. manufacturing deduction tax benefit of $4.3 million were combined with the rate differences between Domestic and International jurisdictions. Fiscal 2014 includes U.S. state income tax benefit of $4.4 million associated with fiscal 2014 acquisitions and integration thereof.
Schedule of Unrecognized Tax Benefit Activity
The following table summarizes the activity related to the Company's unrecognized tax benefits, excluding interest:
 
2016
 
2015
 
2014
Balance at beginning of fiscal year
$
89.2

 
$
82.0

 
$
100.1

Additions related to current year tax positions
63.8

 
4.5

 
3.2

Additions related to prior period tax positions
10.8

 
19.9

 
30.6

Reductions related to prior period tax positions
(37.8
)
 
(7.7
)
 
(33.0
)
Reductions related to disposition transactions
(6.6
)
 

 

Settlements
(2.6
)
 
(7.8
)
 
(6.9
)
Lapse of statute of limitations
(2.0
)
 
(1.7
)
 
(12.0
)
Balance at end of fiscal year
$
114.8

 
$
89.2

 
$
82.0

Schedule of Unrecongized Tax Benefits Balance Sheet Location
Unrecognized tax benefits, excluding interest, are reported in the following consolidated balance sheet captions in the amount shown:
 
September 30, 2016
 
September 25, 2015
Accrued and other current liabilities
$

 
$
1.3

Other income tax liabilities
55.4

 
80.0

Deferred income taxes (non-current liability)
59.4

 
7.9

 
$
114.8

 
$
89.2

Schedule of Income Taxes Payable
Income taxes payable, including uncertain tax positions and related interest accruals, is reported in the following consolidated balance sheet captions in the amounts shown:
 
September 30, 2016
 
September 25, 2015
Accrued and other current liabilities
$
111.8

 
$
15.6

Other income tax liabilities
67.7

 
121.3

 
$
179.5

 
$
136.9

Schedule of Income Tax Receivables and Other Assets
At September 30, 2016, other assets included $69.1 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes $10.0 million of tax payments associated with current deferred intercompany transactions, and $43.5 million of receivables associated with tax payments on account with the taxing authorities. At September 25, 2015, other assets includes $51.7 million of tax payments associated with non-current deferred intercompany transactions. Prepaid expenses and other current assets includes a receivable of $81.1 million and tax payments of $8.7 million associated with current deferred intercompany transactions. All of the above items exclude amounts related to assets which are held for sale.
 
September 30, 2016
 
September 25, 2015
Other assets
$
69.1

 
$
51.7

Prepaid expenses and other current assets
53.5

 
89.8

 
$
122.6

 
$
141.5

Schedule of Deferred Taxes Activity
The components of the net deferred tax (liability) asset at the end of each fiscal year were as follows:
 
September 30, 2016
 
September 25, 2015
Deferred tax assets:
 
 
 
Accrued liabilities and reserves
$
80.8

 
$
91.0

Inventories
35.4

 
21.4

Tax loss and credit carryforwards
332.3

 
159.5

Environmental liabilities
28.6

 
23.6

Rebate reserves
48.7

 
48.1

Expired product
12.2

 
26.3

Postretirement benefits
48.7

 
37.3

Federal and state benefit of uncertain tax positions and interest
17.4

 
33.6

Share-based compensation
22.1

 
17.6

Intangible assets
341.8

 
105.7

Other
14.9

 
8.7

 
982.9

 
572.8

Deferred tax liabilities:
 
 
 
Property, plant and equipment
(111.3
)
 
(111.8
)
Intangible assets
(775.1
)
 
(1,550.7
)
Installment sale
(1,902.9
)
 
(1,465.3
)
Investment in partnership
(186.0
)
 
(187.9
)
 
(2,975.3
)
 
(3,315.7
)
Net deferred tax (liability) before valuation allowances
(1,992.4
)
 
(2,742.9
)
Valuation allowances
(564.9
)
 
(233.0
)
Net deferred tax (liability)
$
(2,557.3
)
 
$
(2,975.9
)

Schedule of Deferred Taxes Balance Sheet Location
Deferred taxes are reported in the following consolidated balance sheet captions in the amounts shown:
 
September 30, 2016
 
September 25, 2015
Deferred income taxes (current asset)
$

 
$
139.2

Other non-current assets
24.1

 
6.6

Accrued and other current liabilities

 
(4.2
)
Deferred income taxes (non-current liability)
(2,581.4
)
 
(3,117.5
)
Net deferred tax (liability)
$
(2,557.3
)
 
$
(2,975.9
)